Whalen v. Roe

1977-02-22

Headline: Ruling allows New York to keep a central computer file of names and addresses for certain powerful prescription drugs, permitting state tracking while finding no general constitutional privacy violation on its face.

Holding: The Court reversed the lower court and held that New York may require reporting patient names and addresses for Schedule II prescriptions into a state computer file without showing a general constitutional privacy violation on the statute's face.

Real World Impact:

Allows New York to collect patient names for Schedule II prescriptions in a state database.
Permits state use of prescription records for investigations into drug diversion.
Could make some patients hesitant to accept needed medications due to disclosure fears.

Topics: patient privacy, prescription drug regulation, government databases, medical records, state public health enforcement

Summary

Background

A group of patients who receive strong prescription drugs, several doctors, and two medical organizations challenged a New York law requiring triplicate prescription forms. One copy of each Schedule II prescription was sent to the State Department of Health, where about 100,000 forms per month were logged, coded, and recorded on computer tapes and kept for five years. The statute included criminal penalties for unauthorized disclosure and departmental rules limiting access. A federal district court enjoined the patient-identification reporting requirement as invading patient privacy.

Reasoning

The Supreme Court addressed whether the State may record patient names and addresses in a central computer file for certain drugs. The Court emphasized New York’s substantial interest in stopping diversion of legally manufactured drugs into unlawful channels and said the record did not show that the reporting system, with its safeguards and limited access, posed a sufficiently grave, facial invasion of privacy. The Court noted prior reporting requirements, evidence from other States, and lack of demonstrated misuse. It therefore reversed the injunction, holding the statute did not on its face violate the Fourteenth Amendment. The doctors’ separate claim that the law unreasonably interfered with medical practice was also rejected as no stronger than the patients’ claim.

Real world impact

The ruling allows New York to continue centralized reporting and limited state tracking of Schedule II prescriptions, potentially aiding drug-diversion investigations. The opinion leaves open future challenges if actual improper disclosures or materially different systems occur. Patients who fear disclosure may still decline treatment, but the record showed large numbers continued to receive these drugs before the injunction.

Dissents or concurrances

Two concurring Justices cautioned differently: one warned about the special risks from central computerized storage and said future limits might be needed, while another stressed that broad privacy protection often remains a matter for state law.